| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |